Skip to content
Back to announcement

20240530_SILO_Laporan Informasi dan Fakta Material_31644455_lamp2.pdf

Other Text extracted SILO

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 2

Page 1
For Immediate Release
PRESS RELEASE
30 May 2024


       Siloam Hospitals Closed the Agenda of the General Meeting of
       Shareholders for Fiscal Year 2023, Shareholders Approved the
       Distribution of Dividends of Rp260 Billion for Fiscal Year 2023

PT Siloam International Hospitals Tbk ("Siloam" or "Company"; stock code: "SILO")

Jakarta, 30 May 2024 – Siloam has closed all agendas of the Annual General Meeting of Shareholders (AGMS)
for the fiscal year 2023 with full support from the shareholders.

The Company sustained its growth trajectory through execution of its 5-year strategy which resulted in
improvement in payer mix, strengthened capabilities to perform higher complexity clinical treatments,
improvements of service quality/patient journey, optimization of network expansion, and transformation of
digital healthcare delivery. As the result of the successful implementation and execution of the strategies
throughout 2023, Siloam’s Revenue, EBITDA, and Net Profit were booked at Rp8.66tn, Rp2.67tn, and
Rp1.25tn, growing 17.2%, 34.6%, and 75.5% compared to 2022.

The AGMS has also approved the distribution of dividends for the financial year 2023 amounting to Rp 260
billion, with a dividend payout ratio (DPR) of 21% of Net Income in 2023. Dividend per share was recorded at
Rp20,- per share. Cash dividend will be paid within 30 business days after the closing of AGM. The remaining
net profit for the 2023 financial is recorded as retained earnings to the Company.

The shareholders authorised the Board of Directors to allocate repurchased shares from the Management
and Employee Share Ownership Program (MESOP) (as approved by the Extraordinary General Meeting of
Shareholders of the Company on 25 May 2023) to eligible participants based on achievement of agreed KPIs
for the purpose of aligning the goals of management with shareholders.

Shareholders approved the appointment of Mr. Rosan Perkasa Roeslani as the President Commissioner of
the Company. Mr. Rosan obtained a Bachelor's degree from the Faculty of Finance at Oklahoma State
University, USA and a Master of Business Administration with a major in International Business Management
from the European University, Antwerp, Belgium. Through his experience and expertise in finance and
management, he developed his abilities and leadership by serving as President Commissioner various
industrie including Investment Committee member at Fortman Cline Asia, Commissioner at Saratoga
Investama Sedaya, Chairman of the Indonesian Chamber of Commerce, and Vice President Commissioner at
PT Pertamina and Indonesian Ambassador for the USA. Management welcomes Mr. Rosan as the President
Commissioners of the Company and look forward for his guidance and wisdom to lead Siloam into next stages
of growth.
Page 2
Siloam’s President Director, Mr. Benny Haryanto, commented on the AGM: “I am delighted to announce that
in 2023, Siloam has achieved exceptional results and set new benchmarks for excellence within the healthcare
industry. My sincere appreciation to our partners, stakeholders, and shareholders for their invaluable support
and collaboration throughout 2023. Management also warmly welcome Mr. Rosan as Siloam’s President
Commissioner. Together, we aim to continue the culture of innovation and excellence that has propelled
Siloam to new heights, and I am confident that our continued partnership will lead to even greater success in
the future.”



For more information, please contact:
Corporate Secretary
Siloam Hospitals Group
corporate.secretary@siloamhospitals.com

About Siloam Hospitals Group
PT Siloam International Hospitals Tbk (“Siloam Hospitals”) is a network of private hospitals in Indonesia committed to providing
high quality health services in Indonesia. Starting business in 1996, Siloam Hospitals currently manages and operates 41 hospitals,
consisting of 15 hospitals in the Greater Jakarta area and 26 hospitals spread across the islands of Java, Sumatra, Kalimantan,
Sulawesi, Bali, Nusa Tenggara and Ambon. Siloam Hospitals Group also operates 73 Siloam Clinics.

Siloam Hospitals' vision is to provide international quality healthcare and reach all levels of society on a national scale based on Godly
compassion which is the basis for Siloam Hospitals to respond to the dynamic social transformation in Indonesia. Siloam Hospitals'
mission is to be the trusted choice for world-class holistic healthcare, health education and research.

Siloam Hospitals is the pioneer of Joint Commission International (JCI) accreditation for hospitals in Indonesia. JCI is an international
accreditation agency based in the United States that focuses on improving the quality of health care and patient safety.

For more information about Siloam Hospitals, visit www.siloamhospitals.com.


Disclaimer: This Press Release is prepared by Siloam Hospitals and is distributed only to convey general information. This Press Release is not intended
for a particular group or purpose and does not constitute a recommendation regarding the shares of Siloam Hospitals. No guarantee is given regarding
the completeness or certainty of the information contained. All opinions and estimates included in this Press Release are our opinions as of this date
and are subject to change without notice. Siloam Hospitals is not responsible for any losses that may occur to any party due to part or all of the
contents of this Press Release, Siloam Hospitals and affiliated companies including their employees and agents are not responsible for any mistakes,
omissions, omissions or inaccuracies that can happen.

Predictive Statements: Some of the statements in this Press Release are or may be predictive in nature. These statements generally contain words
such as "will", "hopes", "anticipates" or the like. By their nature, predictive statements carry risks and uncertainties that may cause realities that are
different from what is explained in this Press Release. Factors that can cause different realities include but are not limited to: the economic, social
and political situation in Indonesia; the health industry situation in Indonesia; market situation; additional regulatory burdens in Indonesia, including
regulations relating to the environment and regulatory compliance costs; fluctuations in foreign exchange rates; interest rate development, capital
costs and capital availability; anticipated demand and supply prices related to our health services and related capital expenditures and other
investments; construction costs; availability of health services; competition from companies and other locations; changes in customer demand;
changes in operational costs, including employee salaries, wages and training, changes in public and government policies; our ability to stay
competitive; financial conditions, business strategies and plans and targets set by our management for future work; procurement of future income;
compliance with environmental and remediation regulations. If, among other things, one or more of the risks or uncertainties mentioned above occur,
the actual results may differ materially than predicted, anticipated or projected. In particular, but not limited, capital costs can increase, projects can
be postponed and anticipated increases in production, capacity or implementation may not all occur. Although we believe that our management's
expectations expressed in predictive statements are reasonable based on the information we have at the moment, we cannot provide guarantees
that these expectations can become reality. You should not depend on these statements immediately. However, these statements apply only to the
date they were stated, and we are not responsible for making updates or revisions, even if new information, new events or anything is available.

File

File Open PDF
Source IDX
Size0.7 MB
Published30 May 2024
Pages2
Characters7,801
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 7 people and organisations named in the text · linked when the evidence is strong

possible org Rosan Perkasa p.1
possible org Saratoga Investama Sedaya p.1
possible org PT Pertamina p.1
unresolved org Rosan Perkasa Roeslani p.1
unresolved person Rosan p.1 ×3
unresolved person Benny Haryanto p.2

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

↑↓ select ↵ open ⇧↵ see every result